Thailand to Amend Bioequivalence Requirement for New Generic Drugs
In August 2011, the Thai FDA announced plans to amend the requirement regulating bioequivalence studies of new generic drugs. This change is made in an effort to expedite the drug approval process and provide more patients access to generic drugs in Thailand... Read More